Dynasty Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Sell
12,115
-94
-0.8% -$14.4K 0.02% 134
2025
Q4
$1.68M Buy
12,209
+579
+5% +$75.8K 0.02% 146
2025
Q3
$1.49M Buy
+11,630
New +$1.42M 0.02% 137

Other funds holding NVS

Dynasty Wealth Management's NVS Position: Q1 2026 in Review

Dynasty Wealth Management reduced its Novartis (NVS) stake by 0.77% in Q1 2026, selling an estimated $14.4K and leaving 12,115 shares worth $1.85M. The position accounts for 0.02% of the portfolio, ranked #134.

Dynasty Wealth Management first reported a position in NVS in Q3 2025 and has held it in 3 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Dynasty Wealth Management held 12,115 shares of Novartis worth $1.85M as of Q1 2026.
  • Dynasty Wealth Management sold 94 Novartis shares in Q1 2026, an estimated $14.4K.
  • Novartis made up 0.02% of Dynasty Wealth Management's portfolio in Q1 2026, its #134 holding.
  • Dynasty Wealth Management first reported a position in Novartis in Q3 2025 and has held it in 3 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Dynasty Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.